Gastrointestinal Pathology
Your trusted leader in GI/Liver testing services
Our specialized GI and liver pathologists work in tandem with clinicians, prioritizing patient well-being through passionate care and utmost professionalism. We offer top-tier GI and liver pathology services, integrating immunohistochemistry with advanced in-house molecular diagnostics, covering panels like KRAS/EGFR Pathways, GIST mutations, Lynch syndrome/HNPCC, MSI-H colon cancer, HCC prognostic testing, and more.
Signature Services
- Molecular PathologyColorectal cancer testing:
- Anti-EGFR Therapy: KRAS, BRAF, NRAS, PIK3CA
- Microsatellite Instability (MSI)
- OncoTracking™ - CRC (Predicts recurrence for early stage CRC)
- C-kit (CD117), PDGFR, BRAF
- HER2 by IHC (assessing HER2 status to guide therapy)*
- Other relevant markers
- HPV-CISH for Human Papillomavirus
- Tests 14 of the most common pathogens for infectious causes of diarrhea.
Comprehensive somatic testing panel
Liquid Biopsy for Drug Resistance - Anatomic Pathology
- Comprehensive IHC test menu, including special stains for organisms and metaplasia
- Upper GI-tract biopsies
- Lower GI-tract biopsies
- Liver biopsies
- Germline TestingLynchNow® for HNPCC/Lynch syndrome:
- NGS-based assays that screens for up to 30 Lynch-associated genes, including MLH1, MSH2, MSH6, PMS2 and EPCAM
- Germline APC testing
*Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): A phase 3, open-label, randomized controlled trial. Lancet. 2010 Oct 16; 376(9742):687-697. Erratum: 2010 Oct 16;376(9749):1302. PubMed 20728210
GI Liver imaging
Through our Aperio and Bioview platforms, our clients have 24/7 access to high-resolution
images and test results.
images and test results.
- Stomach atrophy sprueClick to see the image
- Stomach auto-immune gastritisClick to see the image
- Stomach with stronglyloidesClick to see the image
